LOS ANGELES, CA, January 11, 2022 / 24-7PressRelease / – YoojinBiosoft Co., Ltd. (CEO Jin-tae Yoo) has developed clinical genomic data analysis software and provides program-based analysis services. Since its creation in July 2017, the company has carried out more than 100 statistical analyzes of clinical and genetic data each year.
Its main products include TnF Standard and TnF Interactive, both of which automate statistical analysis of clinical and genetic data, and TnF Preprocess, a data preprocessing program. The company is currently developing TnF Care Solutions, a diagnostic program for aging and biological age. As of December 2021, they had published 44 SCI level clinical papers and in clinical paper statistical methods, software from YoojinBiosoft Co., Ltd. and TnF are specified.
TnF stands for Essential Tables and Figures for Clinical Articles. Using IBM SPSS and SAS, which currently monopolize the global market, can be difficult and time-consuming analysis for people unfamiliar with the statistics. In addition, the costs range from millions of won and can even go up to 20 million won per year, which can be a heavy financial burden.
Thus, YoojinBiosoft’s TnF software has an exploratory data analysis function that automatically finds algorithms based on the characteristics of the data. Researchers who are not familiar with statistics can automatically produce results by entering data into the input window. The software, which is currently patented with national technology, can even automatically analyze big data such as health insurance data, which was difficult for IBM, SPSS and others. In addition, the price is competitive.
YoojinBiosoft CEO Jin-tae Yoo said, “We supply products to more than 35 teaching hospitals and pharmaceutical companies in Korea on the basis of platforms such as TnF Preprocess with data preprocessing functions, TnF Standard which provides automatically tables and images, and TnF Interactive, an AI. -type of statistical analysis product.
In addition, “We are currently analyzing 15 years of follow-up data on 4 million men and 4 million women. By analyzing this health insurance data, we plan to develop and publish TnF Care Solution, a diagnostic program for aging and biological age. Apart from this, we participate in the development of the TnF Interactive software with the support of the Korea Health Industry Promotion Agency (KHIDI).
Regarding future plans, CEO Yoo said, “Based on our statistical platform, we are aiming to participate in a new project called ‘Drug Repositioning’. In addition, we are preparing to collaborate with researchers and professors from various university hospitals, and based on these achievements, we plan to list special technologies in 2024 and 2025. ”
Interview – YoojinBiosoft, Targets List of Special Technologies for Automated Statistical Analysis Program
Hot Spot MIK (MADE IN KOREA) online exhibition is expected to be held regularly according to the field, target market and participating institutions, and it will be presented as a new kind of online business by transforming know-how and values of participating companies according to the trend. Businesses wishing to participate can apply and apply through the Marketing Support Projects of Local Government Support Institutions. Refer to the establishments for more information.
Press release service and press release distribution provided by http://www.24-7pressrelease.com